Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCR-guided extended valacyclovir treatment for prevention of postherpetic neuralgia
ChiCTR2000037264Phase 4Recruiting
- Sponsor
- Shanghai Skin Disease Hospital
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valaciclovir in herpes zoster (HZ) (2 arms), sponsored by Shanghai Skin Disease Hospital. Primary endpoints: Comprehensive efficacy evaluation, Blistering time and 6 more. Started Oct 2020; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2000037264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037264.